Novartis to Highlight Long-Term Data, Innovative Pipeline for Patients With

Novartis to highlight long-term data, innovative pipeline for patients with
The concomitant use of strong CYP3A4 inhibitors or anti-arrhythmic drugs (including, but not limited to, amiodarone, disopyramide, procainamide, quinidine, and sotalol) and other drugs that may prolong the QT interval (including, but not limited to …
Read more on MarketWatch

More Side Effects Of Methadone Long-term Use Information…